» Articles » PMID: 38213585

Take Metabolic Heterogeneity into Consideration when Applying Dietary Interventions to Cancer Therapy: A Review

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Jan 12
PMID 38213585
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, dietary interventions have attracted much attention in cancer therapy. Mechanistic studies suggest that dietary interventions can inhibit the progression of cancer through deprivation of essential metabolites, lowering the levels of protumor hormones, activation of anticancer immunity and synergistic effects with conventional anticancer therapies. The feasibility, safety and promising tumor outcomes have also been established in humans. However, the results from both preclinical and clinical studies are inconsistent or even conflicting, the reasons for which have not been extensively considered. In this review, we discuss the various heterogeneity, including dietary protocols, tissue of origin and cancer locations, spatial and temporal metabolic heterogeneity, and divergent combination treatment, that may affect the responses of different cancers to dietary interventions. Understanding this heterogeneity and taking them into consideration when applying dietary interventions to cancer therapy will allow us to deliver the right diet to the right patient at the right time to maximize compliance, safety and efficacy of conventional anticancer therapy and to improve the outcomes of patients with cancer.

References
1.
Hui S, Cowan A, Zeng X, Yang L, TeSlaa T, Li X . Quantitative Fluxomics of Circulating Metabolites. Cell Metab. 2020; 32(4):676-688.e4. PMC: 7544659. DOI: 10.1016/j.cmet.2020.07.013. View

2.
Egashira R, Matsunaga M, Miyake A, Hotta S, Nagai N, Yamaguchi C . Long-Term Effects of a Ketogenic Diet for Cancer. Nutrients. 2023; 15(10). PMC: 10221628. DOI: 10.3390/nu15102334. View

3.
Pierce J, Natarajan L, Caan B, Parker B, Greenberg E, Flatt S . Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007; 298(3):289-98. PMC: 2083253. DOI: 10.1001/jama.298.3.289. View

4.
Clifton K, Ma C, Fontana L, Peterson L . Intermittent fasting in the prevention and treatment of cancer. CA Cancer J Clin. 2021; 71(6):527-546. DOI: 10.3322/caac.21694. View

5.
Vidoni C, Ferraresi A, Esposito A, Maheshwari C, Dhanasekaran D, Mollace V . Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy. J Cancer Prev. 2022; 26(4):224-236. PMC: 8749320. DOI: 10.15430/JCP.2021.26.4.224. View